BR9909910A - Polipeptìdeo compreendendo o aminoácido de um truncado de proteìna a de ligação à colina de terminal n, vacina derivada dele e seus empregos - Google Patents

Polipeptìdeo compreendendo o aminoácido de um truncado de proteìna a de ligação à colina de terminal n, vacina derivada dele e seus empregos

Info

Publication number
BR9909910A
BR9909910A BR9909910-1A BR9909910A BR9909910A BR 9909910 A BR9909910 A BR 9909910A BR 9909910 A BR9909910 A BR 9909910A BR 9909910 A BR9909910 A BR 9909910A
Authority
BR
Brazil
Prior art keywords
amino acid
polypeptide
choline
truncate
acid sequence
Prior art date
Application number
BR9909910-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Elaine I Tuomanen
Robert H Masure
Theresa M Wizemann
Leslie Sydnor Johnson
Scott Koenig
Original Assignee
St Jude Childrens Res Hospital
Medimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/056,019 external-priority patent/US6858706B2/en
Application filed by St Jude Childrens Res Hospital, Medimmune Inc filed Critical St Jude Childrens Res Hospital
Publication of BR9909910A publication Critical patent/BR9909910A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9909910-1A 1998-04-07 1999-04-07 Polipeptìdeo compreendendo o aminoácido de um truncado de proteìna a de ligação à colina de terminal n, vacina derivada dele e seus empregos BR9909910A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
PCT/US1999/007669 WO1999051188A2 (en) 1998-04-07 1999-04-07 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof

Publications (1)

Publication Number Publication Date
BR9909910A true BR9909910A (pt) 2002-01-15

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909910-1A BR9909910A (pt) 1998-04-07 1999-04-07 Polipeptìdeo compreendendo o aminoácido de um truncado de proteìna a de ligação à colina de terminal n, vacina derivada dele e seus empregos

Country Status (14)

Country Link
JP (1) JP4739521B2 (enExample)
KR (1) KR100638503B1 (enExample)
CN (1) CN1191851C (enExample)
AU (2) AU3479699A (enExample)
BR (1) BR9909910A (enExample)
CA (1) CA2326388C (enExample)
HU (1) HUP0102306A3 (enExample)
IL (1) IL138939A0 (enExample)
MX (1) MXPA00009899A (enExample)
NO (1) NO20005081L (enExample)
NZ (1) NZ507983A (enExample)
PL (1) PL193132B1 (enExample)
TR (1) TR200003498T2 (enExample)
WO (1) WO1999051188A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2808919C (en) 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
KR101579947B1 (ko) 2007-06-26 2015-12-28 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신
WO2009127676A1 (en) 2008-04-16 2009-10-22 Glaxosmithkline Biologicals S.A. Vaccine
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
AU2012257771C1 (en) 2011-05-17 2015-12-03 Glaxosmithkline Biologicals S.A. Vaccine against Streptococcus pneumoniae
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
WO1997041151A2 (en) * 1996-05-01 1997-11-06 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
AU5355398A (en) * 1996-11-12 1998-06-03 Regents Of The University Of Minnesota C3 binding protein of (streptococcus pneumoniae)
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
DE69942176D1 (de) * 1998-04-07 2010-05-06 Medimmune Llc Choline-bindende proteine derivate aus pneumokoken als impfstoff

Also Published As

Publication number Publication date
AU3479699A (en) 1999-10-25
NZ507983A (en) 2004-03-26
KR100638503B1 (ko) 2006-10-26
WO1999051188A9 (en) 2000-10-12
HUP0102306A3 (en) 2008-04-28
CN1191851C (zh) 2005-03-09
CA2326388C (en) 2014-02-04
NO20005081D0 (no) 2000-10-09
CN1342088A (zh) 2002-03-27
PL193132B1 (pl) 2007-01-31
CA2326388A1 (en) 1999-10-14
AU3479799A (en) 1999-10-25
HUP0102306A1 (hu) 2001-09-28
NO20005081L (no) 2000-12-06
MXPA00009899A (es) 2002-05-08
PL347946A1 (en) 2002-04-22
IL138939A0 (en) 2001-11-25
TR200003498T2 (tr) 2001-10-22
AU764811B2 (en) 2003-08-28
KR20010052244A (ko) 2001-06-25
WO1999051188A3 (en) 2001-04-19
JP4739521B2 (ja) 2011-08-03
WO1999051188A2 (en) 1999-10-14
JP2002516662A (ja) 2002-06-11

Similar Documents

Publication Publication Date Title
CA2177837A1 (en) Interleukin-6 (il-6) antagonists
BG101813A (en) Osteoprotegerin
BR0207267A (pt) Proteìnas artificiais com imunogenicidade reduzida
BG102714A (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
NO941186L (no) Hormonanaloger med multiple CTP-forlengelser
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
BG103824A (en) Osteoprotegerin binding proteins and receptors
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BR9909910A (pt) Polipeptìdeo compreendendo o aminoácido de um truncado de proteìna a de ligação à colina de terminal n, vacina derivada dele e seus empregos
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
BR0207016A (pt) Fator neurotrófico derivado de cérebro humano modificado (bdnf) com imunogenicidade reduzida
BR0308860A (pt) Fator viii modificado
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
BR0207014A (pt) Antagonista de receptor de interleucina-1 modificada (il-1ra) com imunogenicidade reduzida.
DE69233311D1 (de) Weidelgraspollen-allergen
WO2000029434A3 (en) PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
BR0207018A (pt) Leptina modificada com imunogenicidade reduzida
NO915084L (no) Fremgangsmaate ved fremstilling av human interleukin-5 receptor
WO2001009328A8 (en) 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
BR0207905A (pt) Protamina modificada com imunogenicidade reduzida
ES2110996T3 (es) Alergeno de polen de ballico.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII E IX) E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.